Riggs Asset Management’s Editas Medicine EDIT Stock Holding History

Riggs Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-200	Closed	-$5K	–	321
2021 Q4	$5K	Hold	200	–	–	﹤0.01%	268
2021 Q3	$8K	Hold	200	–	–	﹤0.01%	239
2021 Q2	$11K	Hold	200	–	–	﹤0.01%	227
2021 Q1	$8K	Sell	200 -200	-50%	-$11.4K	﹤0.01%	223
2020 Q4	$28K	Buy	+400	New	+$16.4K	0.01%	157
2020 Q3	–	Sell	-400	Closed	-$11K	–	178
2020 Q2	$11K	Hold	400	–	–	﹤0.01%	165
2020 Q1	$7K	Hold	400	–	–	﹤0.01%	187
2019 Q4	$12K	Hold	400	–	–	﹤0.01%	195
2019 Q3	$9K	Hold	400	–	–	﹤0.01%	179
2019 Q2	$10K	Hold	400	–	–	0.01%	179
2019 Q1	$9K	Hold	400	–	–	0.01%	179
2018 Q4	$9K	Hold	400	–	–	0.01%	163
2018 Q3	$12K	Sell	400 -100	-20%	-$3.23K	0.01%	167
2018 Q2	$18K	Hold	500	–	–	0.01%	153
2018 Q1	$17K	Buy	500 +100	+25%	+$3.56K	0.01%	170
2017 Q4	$12K	Hold	400	–	–	﹤0.01%	186
2017 Q3	$10K	Sell	400 -100	-20%	-$1.9K	﹤0.01%	193
2017 Q2	$8K	Sell	500 -200	-29%	-$3.6K	﹤0.01%	226
2017 Q1	$16K	Buy	+700	New	+$14.5K	0.01%	174

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Riggs Asset Management's EDIT Position: Q1 2022 in Review

Riggs Asset Management sold out of Editas Medicine (EDIT) in Q1 2022, closing a stake of 200 shares — an estimated $5K sold.

Riggs Asset Management first reported a position in EDIT in Q1 2017 and held it in 19 quarters. The position peaked at $28K in Q4 2020. 256 funds tracked by Wall St. Rank hold EDIT as of Q1 2022.

Riggs Asset Management reported no remaining Editas Medicine position as of Q1 2022 after selling out during the quarter.
Riggs Asset Management sold 200 Editas Medicine shares in Q1 2022, an estimated $5K.
Riggs Asset Management first reported a position in Editas Medicine in Q1 2017 and held it in 19 quarters.
Riggs Asset Management's Editas Medicine position peaked at $28K in Q4 2020.
256 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2022.

Based on Riggs Asset Management's 13F filing for Q1 2022, filed 5 May 2022.